Insights into the pathogenesis and genetic background of patency of the ductus arteriosus
- PMID: 19955832
- DOI: 10.1159/000262481
Insights into the pathogenesis and genetic background of patency of the ductus arteriosus
Abstract
The unique differentiation program of the ductus arteriosus (DA) is essential for its specific task during fetal life and for the adapting circulation after birth. Phenotypic changes occur in the DA during the normal maturation and definitive closure. Morphological abnormalities of the vessel wall characterize the persistent DA (PDA) in older children. Here, we give an overview of the animal models of DA regulation and remodeling. Genetic research has identified the cause of syndromic forms of PDA, such as the TFAP2B mutations in Char syndrome. Genes that interfere with the remodeling of vascular smooth muscle cells (VSMCs) of the ductal media are affected in virtually all of these anomalies. Therefore, the pivotal regulatory role of VSMCs is emphasized. A better understanding of the genetic background of this developmental process may help develop new strategies to manipulate the DA in premature infants, neonates with duct-dependent anomalies, and patients with syndromic and non-syndromic PDA.
Similar articles
-
Genetics of patent ductus arteriosus susceptibility and treatment.Semin Perinatol. 2012 Apr;36(2):98-104. doi: 10.1053/j.semperi.2011.09.019. Semin Perinatol. 2012. PMID: 22414880 Review.
-
Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus.Nat Genet. 2000 May;25(1):42-6. doi: 10.1038/75578. Nat Genet. 2000. PMID: 10802654
-
Patent ductus arteriosus in the preterm infant: new insights into pathogenesis and clinical management.J Matern Fetal Neonatal Med. 2010 Oct;23 Suppl 3:34-7. doi: 10.3109/14767058.2010.509920. J Matern Fetal Neonatal Med. 2010. PMID: 20836735 Review.
-
Oxygen-sensitive Kv channel gene transfer confers oxygen responsiveness to preterm rabbit and remodeled human ductus arteriosus: implications for infants with patent ductus arteriosus.Circulation. 2004 Sep 14;110(11):1372-9. doi: 10.1161/01.CIR.0000141292.28616.65. Epub 2004 Sep 7. Circulation. 2004. PMID: 15353504
-
Tfap2b mutation in mice results in patent ductus arteriosus and renal malformation.J Surg Res. 2018 Jul;227:178-185. doi: 10.1016/j.jss.2018.02.038. Epub 2018 Mar 19. J Surg Res. 2018. PMID: 29804851
Cited by
-
Identification of differentially regulated genes in human patent ductus arteriosus.Exp Biol Med (Maywood). 2016 Dec;241(18):2112-2118. doi: 10.1177/1535370216661778. Epub 2016 Jul 28. Exp Biol Med (Maywood). 2016. PMID: 27465141 Free PMC article.
-
Vav2 promotes ductus arteriosus anatomic closure via the remodeling of smooth muscle cells by Rac1 activation.J Mol Med (Berl). 2023 Dec;101(12):1567-1585. doi: 10.1007/s00109-023-02377-6. Epub 2023 Oct 7. J Mol Med (Berl). 2023. PMID: 37804474
-
Isolated Dissection of the Ductus Arteriosus Associated with Sudden Unexpected Intrauterine Death.J Cardiovasc Dev Dis. 2021 Jul 31;8(8):91. doi: 10.3390/jcdd8080091. J Cardiovasc Dev Dis. 2021. PMID: 34436233 Free PMC article.
-
[Effectiveness and safety of the surgical closure of permeable arteriosus conduct by the general pediatric surgeon: clinical trial].Arch Cardiol Mex. 2021;91(1):73-83. doi: 10.24875/ACM.20000014. Arch Cardiol Mex. 2021. PMID: 33661880 Free PMC article. Spanish.
-
Characterization of transcription factor AP-2 β mutations involved in familial isolated patent ductus arteriosus suggests haploinsufficiency.J Surg Res. 2014 May 15;188(2):466-472. doi: 10.1016/j.jss.2014.01.015. Epub 2014 Jan 12. J Surg Res. 2014. PMID: 24507797 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources